These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 27388873

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A refined and updated health impact assessment of the Global Programme to Eliminate Lymphatic Filariasis (2000-2020).
    Turner HC, Ottesen EA, Bradley MH.
    Parasit Vectors; 2022 May 28; 15(1):181. PubMed ID: 35643508
    [Abstract] [Full Text] [Related]

  • 3. The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007).
    Chu BK, Hooper PJ, Bradley MH, McFarland DA, Ottesen EA.
    PLoS Negl Trop Dis; 2010 Jun 01; 4(6):e708. PubMed ID: 20532228
    [Abstract] [Full Text] [Related]

  • 4. The Health and Economic Burdens of Lymphatic Filariasis Prior to Mass Drug Administration Programs.
    Mathew CG, Bettis AA, Chu BK, English M, Ottesen EA, Bradley MH, Turner HC.
    Clin Infect Dis; 2020 Jun 10; 70(12):2561-2567. PubMed ID: 31343064
    [Abstract] [Full Text] [Related]

  • 5. The global programme to eliminate lymphatic filariasis: health impact after 8 years.
    Ottesen EA, Hooper PJ, Bradley M, Biswas G.
    PLoS Negl Trop Dis; 2008 Oct 08; 2(10):e317. PubMed ID: 18841205
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Elimination of lymphatic filariasis as a public health problem in Malawi.
    Chiphwanya J, Mkwanda S, Kabuluzi S, Mzilahowa T, Ngwira B, Matipula DE, Chaponda L, Ndhlova P, Katchika P, Mahebere Chirambo C, Moses P, Kumala J, Chiumia M, Barrett C, Betts H, Fahy J, Rebollo Polo M, Reimer L, Stanton MC, Thomas B, Freer S, Molyneux DH, Bockarie MJ, Mackenzie CD, Taylor MJ, Martindale S, Kelly-Hope LA.
    PLoS Negl Trop Dis; 2024 Feb 08; 18(2):e0011957. PubMed ID: 38363794
    [Abstract] [Full Text] [Related]

  • 9. Health economic analyses of the Global Programme to Eliminate Lymphatic Filariasis.
    Turner HC.
    Int Health; 2020 Dec 22; 13(Suppl 1):S71-S74. PubMed ID: 33349885
    [Abstract] [Full Text] [Related]

  • 10. Assessing progress in reducing the at-risk population after 13 years of the global programme to eliminate lymphatic filariasis.
    Hooper PJ, Chu BK, Mikhailov A, Ottesen EA, Bradley M.
    PLoS Negl Trop Dis; 2014 Nov 22; 8(11):e3333. PubMed ID: 25411843
    [Abstract] [Full Text] [Related]

  • 11. Modelling the health impact and cost-effectiveness of lymphatic filariasis eradication under varying levels of mass drug administration scale-up and geographic coverage.
    Stone CM, Kastner R, Steinmann P, Chitnis N, Tanner M, Tediosi F.
    BMJ Glob Health; 2016 Nov 22; 1(1):e000021. PubMed ID: 28588916
    [Abstract] [Full Text] [Related]

  • 12. The Socioeconomic Benefit to Individuals of Achieving the 2020 Targets for Five Preventive Chemotherapy Neglected Tropical Diseases.
    Redekop WK, Lenk EJ, Luyendijk M, Fitzpatrick C, Niessen L, Stolk WA, Tediosi F, Rijnsburger AJ, Bakker R, Hontelez JA, Richardus JH, Jacobson J, de Vlas SJ, Severens JL.
    PLoS Negl Trop Dis; 2017 Jan 22; 11(1):e0005289. PubMed ID: 28103243
    [Abstract] [Full Text] [Related]

  • 13. Progress and impact of 13 years of the global programme to eliminate lymphatic filariasis on reducing the burden of filarial disease.
    Ramaiah KD, Ottesen EA.
    PLoS Negl Trop Dis; 2014 Nov 22; 8(11):e3319. PubMed ID: 25412180
    [Abstract] [Full Text] [Related]

  • 14. Information technology in morbidity management of human lymphatic filariasis-A promising tool in global programme for elimination of lymphatic filariasis.
    Devi RR, Raju V.
    J Vector Borne Dis; 2018 Nov 22; 55(1):20-25. PubMed ID: 29916444
    [Abstract] [Full Text] [Related]

  • 15. Economic evaluations of lymphatic filariasis interventions: a systematic review and research needs.
    Gedge LM, Bettis AA, Bradley MH, Hollingsworth TD, Turner HC.
    Parasit Vectors; 2018 Feb 01; 11(1):75. PubMed ID: 29391042
    [Abstract] [Full Text] [Related]

  • 16. The role of medicine donations in the global programme for the elimination of lymphatic filariasis.
    Williams T, Taylor R, Iwamoto M, Hida T, Gusovsky F.
    Int Health; 2020 Dec 22; 13(Suppl 1):S39-S43. PubMed ID: 33349878
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Lessons from lymphatic filariasis elimination and the challenges of post-elimination surveillance in China.
    Fang Y, Zhang Y.
    Infect Dis Poverty; 2019 Aug 07; 8(1):66. PubMed ID: 31387644
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.